JMD ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuetz, A. N.
Right arrow Articles by Young, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuetz, A. N.
Right arrow Articles by Young, A. N.
JMD 2005, Vol. 7, No. 2
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

Molecular Classification of Renal Tumors by Gene Expression Profiling

Audrey N. Schuetz*, Qiqin Yin-Goen*{dagger}, Mahul B. Amin*{ddagger}§, Carlos S. Moreno*{ddagger}, Cynthia Cohen*, Christopher D. Hornsby*, Wen Li Yang*{dagger}, John A. Petros*{dagger}{ddagger}§, Muta M. Issa{dagger}§, John G. Pattaras§, Kenneth Ogan§, Fray F. Marshall§ and Andrew N. Young*{dagger}

From the Departments of Pathology and Laboratory Medicine * and Urology, § and the Winship Cancer Institute, {ddagger} Emory University School of Medicine, Atlanta; and the Atlanta Veterans Affairs Medical Center, {dagger} Decatur, Georgia

Renal tumor classification is important because histopathological subtypes are associated with distinct clinical behavior. However, diagnosis is difficult because tumor subtypes have overlapping microscopic characteristics. Therefore, ancillary methods are needed to optimize classification. We used oligonucleotide microarrays to analyze 31 adult renal tumors, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, oncocytoma, and angiomyolipoma. Expression profiles correlated with histopathology; unsupervised algorithms clustered 30 of 31 tumors according to appropriate diagnostic subtypes while supervised analyses identified significant, subtype-specific expression markers. Clear cell RCC overexpressed proximal nephron, angiogenic, and immune response genes, chromophobe RCC oncocytoma overexpressed distal nephron and oxidative phosphorylation genes, papillary RCC overexpressed serine protease inhibitors, and extracellular matrix products, and angiomyolipoma overexpressed muscle developmental, lipid biosynthetic, melanocytic, and distinct angiogenic factors. Quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry of formalin-fixed renal tumors confirmed overexpression of proximal nephron markers (megalin/low-density lipoprotein-related protein 2, {alpha}-methylacyl CoA racemase) in clear cell and papillary RCC and distal nephron markers (ß-defensin 1, claudin 7) in chromophobe RCC/oncocytoma. In summary, renal tumor subtypes were classified by distinct gene expression profiles, illustrating tumor pathobiology and translating into novel molecular bioassays using fixed tissue.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
S. Kuhn, M. Koch, T. Nubel, M. Ladwein, D. Antolovic, P. Klingbeil, D. Hildebrand, G. Moldenhauer, L. Langbein, W. W. Franke, et al.
A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression
Mol. Cancer Res., June 1, 2007; 5(6): 553 - 567.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Rohan, J. J. Tu, J. Kao, P. Mukherjee, F. Campagne, X. K. Zhou, E. Hyjek, M. A. Alonso, and Y.-T. Chen
Gene Expression Profiling Separates Chromophobe Renal Cell Carcinoma from Oncocytoma and Identifies Vesicular Transport and Cell Junction Proteins as Differentially Expressed Genes
Clin. Cancer Res., December 1, 2006; 12(23): 6937 - 6945.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology and the Association for Molecular Pathology.